ArticleTherapeutic advances in gastroenterology2019

Soluble human Suppression of Tumorigenicity 2 is associated with endoscopic activity in patients with moderate-to-severe ulcerative colitis treated with golimumab.

Fernando Magro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.